z-logo
Premium
Atopic dermatitis and the metabolic syndrome: a cross‐sectional study of 116 816 patients
Author(s) -
Shalom G.,
Dreiher J.,
Kridin K.,
Horev A.,
Khoury R.,
Battat E.,
Freud T.,
Comaneshter D.,
Cohen A.D.
Publication year - 2019
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.15642
Subject(s) - medicine , metabolic syndrome , atopic dermatitis , diabetes mellitus , obesity , cross sectional study , population , multivariate analysis , gastroenterology , dermatology , endocrinology , pathology , environmental health
Background Data regarding the association between atopic dermatitis ( AD ) and the metabolic syndrome are controversial. Objective To evaluate the prevalence of the metabolic syndrome and its components in a large group of patients with AD compared to a matched reference group. Methods A cross‐sectional study of AD patients diagnosed by a dermatologist between 1998 and 2016, and a matched comparison group was performed. We analysed the association between AD and metabolic syndrome, its components and possible complications for the entire study population, adults (age > 18) and adults with moderate‐to‐severe AD . Results The study included 116 816 patients with AD and 116 812 comparison enrollees. AD in the entire group of patients and in the adult patients was associated with a higher prevalence of dyslipidaemia and a lower prevalence of diabetes and metabolic syndrome. Moderate and severe AD were associated, respectively, with higher prevalence rates of the metabolic syndrome (17.0% vs. 9.4%), its components (obesity: 22.2% vs. 18.6%; diabetes: 15.9% vs. 9.2%; hypertension 27.9% vs. 15.3%; dyslipidaemia 47.1% vs. 28.5%, all P values < 0.001) and cardiovascular morbidity (all P values < 0.001). Multivariate analysis demonstrated a significant overrepresentation of the metabolic syndrome in moderate‐to‐severe AD ( P  = 0.04). Conclusions Severely affected patients with AD may have one or more undiagnosed components of metabolic syndrome.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here